Economic Atlas
Companies/Wayland Group Corp.
Company profile

Wayland Group Corp.

OTC: MRRCF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Oakville, ONReports USD
#777 of 1,422 Healthcare companies by revenue28th-percentile growth
EA Score
——
Revenue TTM
$2.5M
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$51.6M
Employees
68
as of 2026-08-04
Market cap
$2.1k
as of 2026-08-04

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$2.5M$2.5M2017
Net income-$51.6M-$51.6M2017
Operating income-$21.3M-$21.3M2017
Total assets$74.5M$74.5M2017
Liabilities$25.4M$25.4M2017
Equity$49.1M$49.1M2017

Revenue trend

FY2015 – FY2017 · USD
FY15
FY16
FY17

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Wayland Group Corp.’s revenue?

Wayland Group Corp. booked $2.5M in FY2017 revenue, contracting 19% year over year — slower than 72% of Healthcare companies we track, at a -2079.4% net margin.

Peers · Healthcare
ENvue Medical, Inc.46DFiore Cannabis Ltd.——GeoVax Labs, Inc.38DLattice Biologics Ltd.——Quantum-Si incorporated40DDNAPrint Genomics, Inc.——
Key facts
CEODavid Miller
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersOakville, ON
ExchangeOTC: MRRCF
Employees68
IPO date2001-05-07
Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.